Evaluating the relationship between the radial pulse wave and gynecological disease

Not Applicable

Completed

• Conditions: Risk factors in gynecological diseases; Urological and Genital Diseases

• Registration Number: ISRCTN20480882
• Lead Sponsor: Taipei City Hospital

Brief Summary

2019 Abstract results in https://doi.org/10.1161/res.125.suppl_1.176 (added 13/09/2022) 2019 Abstract results in https://doi.org/10.1161/res.125.suppl_1.445 (added 13/09/2022) 2019 Abstract results in https://doi.org/10.1161/res.125.suppl_1.446 (added 13/09/2022) 2019 Abstract results in https://www.ahajournals.org/doi/10.1161/circ.140.suppl_1.10139 (added 13/09/2022) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34507667/ (added 13/09/2022) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34714885/ (added 13/09/2022)

Detailed Description

Not available

Study Timeline

• Study Start: 2020-05-25
• Study Completion: 2022-03-31
• Last Update Posted: 8 July 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 825

Inclusion Criteria

1. Patients with gynecological diseases
2. Over 20 years old

Exclusion Criteria

Severe diseases or acute symptoms are excluded if the pressure wave measurement could not be performed

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Radial blood pressure wave is assessed using a miniature pressure transducer (TD01C, Taiwan) at time of enrollment<br>2. Hormones (such as E2, LH, FSH and Prolactin) are assessed using blood test at time of enrollment<br>3. CA-125 and AFP are assessed using blood test at time of enrollment

Secondary Outcome Measures

Name	Time	Method
Physician diagnosis from the medical record at time of enrollment.